Showing 13,601 - 13,620 results of 101,390 for search '(( 5 wt decrease ) OR ( 5 ((((we decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.75s Refine Results
  1. 13601
  2. 13602
  3. 13603

    Key safety measures including adverse events. by Anuja Dokras (8679261)

    Published 2025
    “…<div><p>Background</p><p>The risk-to-benefit ratio of using combined oral contraceptive pills (COCPs) and/or metformin for comprehensive management of polycystic ovary syndrome (PCOS) in women with obesity is unclear. As there is a lack of robust evidence on the impact of these first-line medications on cardiovascular disease (CVD) risk, we compared the effect of COCPs, metformin or both on prevalence of metabolic syndrome (MetS) in participants with hyperandrogenic PCOS and hypothesized that COCPs would increase prevalence of MetS while metformin would decrease prevalence of MetS.…”
  4. 13604
  5. 13605
  6. 13606
  7. 13607
  8. 13608
  9. 13609
  10. 13610
  11. 13611

    The Numerical data used in all figures. by Fa Dai (15810913)

    Published 2023
    “…However, the mechanism on how AJ01 breaks the AjTmod-stabilized cytoskeleton for internalization remains unclear. Here, we identified a novel AJ01 Type III secretion system (T3SS) effector of leucine-rich repeat-containing serine/threonine-protein kinase (STPKLRR) with five LRR domains and a serine/threonine kinase (STYKc) domain, which could specifically interact with tropomodulin domain of AjTmod. …”
  12. 13612

    Primers. by Fa Dai (15810913)

    Published 2023
    “…However, the mechanism on how AJ01 breaks the AjTmod-stabilized cytoskeleton for internalization remains unclear. Here, we identified a novel AJ01 Type III secretion system (T3SS) effector of leucine-rich repeat-containing serine/threonine-protein kinase (STPKLRR) with five LRR domains and a serine/threonine kinase (STYKc) domain, which could specifically interact with tropomodulin domain of AjTmod. …”
  13. 13613
  14. 13614

    Image1_Restricting Glutamine Uptake Enhances NSCLC Sensitivity to Third-Generation EGFR-TKI Almonertinib.TIF by Yaming Liu (4908724)

    Published 2021
    “…The combination of SLC1A5 inhibitor V9302 and Almonertinib had a synergistic inhibitory effect on the proliferation of NSCLC. …”
  15. 13615
  16. 13616
  17. 13617
  18. 13618

    Ab Initio Study of the Substituent Effects on the Relative Stability of the <i>E</i> and <i>Z</i> Conformers of Phenyl Esters. Stereoelectronic Effects on the Reactivity of the Car... by Helmi Neuvonen (2643793)

    Published 2005
    “…ED/EW substituents adjust the availability of the π*<sub>C</sub><sub></sub><sub>O</sub> antibonding orbital to interact with the lone pair orbital of the attacking nucleophile and therefore affect the reactivity:  EW substituents increase and ED substituents decrease it. Excellent correlations were observed between the rate coefficients of nucleophilic acyl substitutions and π*<sub>C</sub><sub></sub><sub>O</sub> occupancies of the ester series <b>4 </b>and <b>5</b>.…”
  19. 13619

    Maternal exposure to U-46619 decreases fetal body weight at E19 compared to sham pups. by Camille M. Fung (844334)

    Published 2016
    “…<p>Pregnant mice were exposed to a TXA<sub>2</sub>- analog (U-46619) or vehicle via micro-osmotic pump infusion from E12.5 until birth (term ~20 days). …”
  20. 13620

    Three New Phases in the K/Cu/Th/S System:  KCuThS<sub>3</sub>, K<sub>2</sub>Cu<sub>2</sub>ThS<sub>4</sub>, and K<sub>3</sub>Cu<sub>3</sub>Th<sub>2</sub>S<sub>7</sub> by Hugh D. Selby (2038372)

    Published 2005
    “…All three phases are semiconductors with optical band gaps of 2.95, 2.17, and 2.49 eV(<b>I</b>−<b>III</b>). Compound <b>I</b> crystallizes in the orthorhombic space group <i>Cmcm</i> with <i>a </i>= 4.076(1) Å, <i>b</i> = 13.864(4) Å, and <i>c</i> = 10.541(3) Å. …”